Chinese CRO Adopts Medidata CTMS

R&G Pharma Studies, a Beijing, China-based CRO, has broadened its adoption of Medidata's Clinical Cloud, becoming the first Chinese customer to use Medidata CTMS.^® R&G provides a full range of clinical trial services-including regulatory affairs, clinical monitoring, data management capabilities, biostatistics, pharmacoeconomics, site management organization (SMO) services, and staffing and outsourcing-supporting studies on both a global and domestic scale.

Read the full release.